Details for Patent: 6,423,340

✉ Email this page to a colleague

Summary for Patent: 6,423,340

Patent landscape, scope, and claims:

Title:	Method for the treatment of inflammatory bowel diseases
Abstract:	Described herein are methods comprising the oral administration of budesonide for the treatment of ulcerative colitis and Crohn's colitis in its active phase. The methods can also be applied as relapse preventing therapy for Crohn's colitis in its chronic phase and Crohn's disease in the small intestine.
Inventor(s):	Ulmius; Jan (Lund, SE)
Assignee:	Aktiebolaget Draco (Sodertalje, SE)
Application Number:	09/159,301
Patent Claim Types: see list of patent claims	Use; Formulation; Dosage form;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 6,423,340

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,423,340

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	8903914	Nov 15, 1990

PCT Information
PCT Filed	November 15, 1990	PCT Application Number:	PCT/SE90/00738
PCT Publication Date:	May 30, 1991	PCT Publication Number:	WO91/07172

International Family Members for US Patent 6,423,340

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	125445	⤷ Subscribe
Australia	643021	⤷ Subscribe
Australia	7786491	⤷ Subscribe
Canada	2071518	⤷ Subscribe
Germany	502092	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.